Trial intelligence / Profile preview

Wenyang Huoxue Decoction in Heart Failure After Myocardial Infarction

NCT04695990Phase 2Unknown

Start
Jan 2021
Primary completion
Mar 2022
Modality
Drug Delivery Systems
01

Overview

Phase 2, randomised, double-blind trial of Wenyang Huoxue Decoction in heart failure (HF). Status: unknown.

02

Drugs

Wenyang Huoxue Decoction
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT04695990.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04695990.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call